Cell Selection for Cell Therapy
Obtaining and qualifying a robust starting cell population is the essential first step for an ex vivo manufacturing workflow. This process must be efficient, clean, and reproducible. By coupling innovative cell selection technologies with robust flow cytometry antibodies for cell qualification, Bio‑Techne is creating a new standard for cell separation.
Collect and Qualify
The quality of the cells that enter your manufacturing pipeline will directly impact the efficiency of your cell expansion or differentiation protocols. Establish standardized, long-term cell qualification protocols using Bio-Techne antibodies.
Solutions that make this possible:
Start at Discovery. Go to the Clinic.
Grow your research into a therapy with innovative tools and trusted reagents. Bio-Techne is a full workflow provider from discovery to the clinic, including research-grade cell separation and phenotyping tools.
Custom Solutions for Cell Therapy
Efficient workflows often require customized solutions. Put our decades of experience to work for you. View our portfolio of services for customizing your cell therapy manufacturing workflow.